COURSE CREDITS & HOURS
1.5 AMA PRA Category 1 Credits™15 ACPE Credits
15.0 Contact Hours
COURSE FEES
In Person Conference Registration:
3 Day Fee: $675
2 Day Fee: $575
1 Day Fee: $475
Conference Surcharge if not staying on site at hotel: $50.00 (see Conference Policies)
Live Stream Webcast Registration:
3 Day Fee: $550
2 Day Fee: $450
1 Day Fee: $350
3 Day Fee: $675
2 Day Fee: $575
1 Day Fee: $475
Conference Surcharge if not staying on site at hotel: $50.00 (see Conference Policies)
Live Stream Webcast Registration:
3 Day Fee: $550
2 Day Fee: $450
1 Day Fee: $350
In Person Conference registration includes workshop attendance, handouts, breakfast or refreshments during the meetings and documentation of continuing education credit*.
Live Stream Webcast registration includes live conference streaming, access to online course materials and documentation of continuing education credit*.
Spouses, family and friends are welcome and do not need to register unless they attend the educational sessions. Special seminar fees are available for non-professional accompanying persons who wish to attend one or more session (no special receipt, certification or credit issued).
Live Stream Webcast registration includes live conference streaming, access to online course materials and documentation of continuing education credit*.
Spouses, family and friends are welcome and do not need to register unless they attend the educational sessions. Special seminar fees are available for non-professional accompanying persons who wish to attend one or more session (no special receipt, certification or credit issued).
TARGET AUDIENCE
Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists
PROGRAM TOPICS
SESSION 1 SCHEDULE
Hot Topics in Infectious Diseases: New Antimicrobials, Penicillin Allergy De-labeling, Shorter Durations of Therapy, and more IV to PO conversion in complicated infections
5 hours | Wednesday, 6/9/2021
Check-in and Breakfast: 7:30AM PST
Educational Session: 8:00AM – 1:30PM PST
At the conclusion of this program, the participant will be able to:
- Review various newer antimicrobials that have been FDA-approved.
- Evaluate these agents critically for use in clinical practice.
- Discuss penicillin allergies including long-term implications.
- Describe process and recent data supporting intervention strategies to de-label patients.
- Describe disease states for which shorter durations of therapy data are growing.
- Describe new recommendations to recently published asthma guidelines.
- Discuss changes in asthma medication recommendations.
- Discuss current role of traditional agents for migraine prophylaxis.
- Describe role of newer CGRP antagonists within migraine prophylaxis.
- Review acute effects of COVID-19 on the primary care provider.
- Provide guidance in managing long-term complications of COVID-19 for the primary care provider.
- Review medications and lifestyle modifications that are recommended for the treatment and prevention of cardiovascular disease.
- Explain recommendations from the American College of Cardiology/American Heart Association guidelines for treatment of patients with hypertension, hypercholesterolemia, heart failure with reduced ejection fraction, peripheral arterial disease and atrial fibrillation.
- Formulate a care plan for patients with resistant hypertension based on the 2018 American Heart Association scientific statement.
- Describe the evidence supporting bedtime dosing of antihypertensive medications.
- Apply the treatment approaches recommended in the 2018 ACC-AHA cholesterol guideline to patients with hypercholesterolemia.
- Define the evidence and role in therapy of nonstatin medications in the treatment of hypercholesterolemia.
- Examine results from cardiovascular outcome trials evaluating the use of angiotensin–neprilysin inhibition in heart failure with reduce ejection fraction.
- Compare and contrast the evidence and guideline recommendations supporting the use of antiplatelet therapy for primary and secondary prevention patients.
- Examine the evidence-based CV risk reduction benefits of medications used to treat type 2 diabetes.
- Create treatment plans that reduce the risk of cardiovascular disease.
IMPORTANT INFORMATION
PLEASE NOTE: To attend the conference, participants must book their cruise accommodations through Continuing Education, Inc. This ensures we can provide full conference services and complimentary social amenities to meeting participants and guests. Participants' family and friends are welcome to book within our group allotment to take advantage of our typically excellent rates. Thanks for your cooperation. We look forward to welcoming you aboard!
BIAS FREE CME - No Commercial Support was provided for this CME activity.
